Myelin brain disorder research biobank for samples and data
Part of Bones, joints & muscles, Brain & nervous system, Digestive system, Eyes & vision, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Kidney & urinary, Mental health, Mouth & dental, Skin, Women’s health & pregnancy clinical trials.
This study collects brain-related medical information and biological samples to help researchers better understand leukodystrophies and other white-matter brain disorders. It may help future diagnosis and treatments by building a valuable “biobank” of patient data and samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or confirmed leukodystrophy or similar white-matter brain disorder (based on brain scans or a genetic result)
- Or you are a healthy person with no suspected or confirmed white-matter brain disorder
- You (or your parent/legal guardian) can give consent, and you may need to agree if you’re old enough
- You are willing to share medical information and do standard study checkups and/or provide samples (like blood or other samples, if requested)
- Your diagnosis (if you’re being evaluated) should not be from an acquired cause like infection or multiple sclerosis—except certain long-term effects from infections present from birth
- You are able to provide consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune cells in blood to better understand rare brain conditions caused by genetic changes. It may help researchers understand why symptoms happen and how the immune system is involved.
This study follows people with inherited leukodystrophies to better understand how the condition is diagnosed and how it changes over time. It may help doctors improve testing and care planning by collecting clinical and imaging information.
This trial follows people with genetic neurodegenerative (brain-wasting) disorders over time to better understand how the condition changes. The goal is to learn patterns that could help future treatments or care plans.
This study collects health information and test results from people with X-linked adrenoleukodystrophy (X-ALD) and some genetic carriers. It helps researchers better understand the condition and how it varies, which can guide future care and studies.
This study checks whether a brain MRI scan can confirm a blood/planning marker that predicts how X-linked adrenoleukodystrophy (ALD) may progress. If you have ALD, it may help researchers better track the condition using safer, non-invasive imaging.
This study builds a blood and spinal fluid (lumbar puncture) sample library from people with ALS, ALS-FTD, or similar neurodegenerative diseases. Your samples help researchers study these conditions, even if you are not receiving a new treatment.
Hear when a new Leukodystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.